XILIO THERAPEUTICS INC's ticker is and the CUSIP is 98422T100. A total of 32 filers reported holding XILIO THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $62,931 | +28.5% | 66,418 | +46.4% | 0.00% | – |
| Q1 2024 | $48,983 | +90.0% | 45,355 | -3.2% | 0.00% | – |
| Q4 2023 | $25,774 | -74.2% | 46,862 | -1.1% | 0.00% | – |
| Q3 2023 | $99,981 | -22.5% | 47,384 | -3.7% | 0.00% | – |
| Q2 2023 | $128,933 | -20.3% | 49,211 | -3.5% | 0.00% | – |
| Q1 2023 | $161,686 | +21.6% | 51,005 | +3.2% | 0.00% | – |
| Q4 2022 | $132,991 | -1.5% | 49,439 | +6.6% | 0.00% | – |
| Q3 2022 | $135,000 | -2.9% | 46,358 | -2.7% | 0.00% | – |
| Q2 2022 | $139,000 | -93.4% | 47,663 | -84.1% | 0.00% | – |
| Q1 2022 | $2,119,000 | -59.1% | 299,756 | -7.5% | 0.00% | – |
| Q4 2021 | $5,184,000 | – | 324,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,441,444 | $1,365,768 | 20.01% |
| Bain Capital Life Sciences Investors, LLC | 3,785,450 | $3,586,714 | 0.39% |
| Rock Springs Capital Management LP | 3,003,259 | $2,845,588 | 0.09% |
| SevenBridge Financial Group, LLC | 41,000 | $37,179 | 0.01% |
| Dunhill Financial, LLC | 10,274 | $9,735 | 0.01% |
| Pinnacle Financial Group, LLC / IL | 10,000 | $9,475 | 0.00% |
| XTX Topco Ltd | 33,289 | $31,541 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 71,081 | $67,349 | 0.00% |
| Avantax Planning Partners, Inc. | 25,000 | $23,688 | 0.00% |
| BlackRock Finance, Inc. | 66,418 | $62,931 | 0.00% |